Gerresheimer AG (GRRMF)
32.20
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Gerresheimer Enterprise Value : 3.463B for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 3.463B |
| August 24, 2026 | 3.463B |
| August 21, 2026 | 3.426B |
| August 20, 2026 | 3.426B |
| August 19, 2026 | 3.426B |
| August 18, 2026 | 3.426B |
| August 17, 2026 | 3.426B |
| August 14, 2026 | 3.426B |
| August 13, 2026 | 3.426B |
| August 12, 2026 | 3.426B |
| August 11, 2026 | 3.426B |
| August 10, 2026 | 3.358B |
| August 07, 2026 | 3.358B |
| August 06, 2026 | 3.445B |
| August 05, 2026 | 3.445B |
| August 04, 2026 | 3.445B |
| August 03, 2026 | 3.445B |
| July 31, 2026 | 3.445B |
| July 30, 2026 | 3.415B |
| July 29, 2026 | 3.415B |
| July 28, 2026 | 3.415B |
| July 27, 2026 | 3.415B |
| July 24, 2026 | 3.415B |
| July 23, 2026 | 3.415B |
| July 22, 2026 | 3.415B |
| Date | Value |
|---|---|
| July 21, 2026 | 3.415B |
| July 20, 2026 | 3.503B |
| July 17, 2026 | 3.503B |
| July 16, 2026 | 3.503B |
| July 15, 2026 | 3.503B |
| July 14, 2026 | 3.503B |
| July 13, 2026 | 3.503B |
| July 10, 2026 | 3.503B |
| July 09, 2026 | 3.503B |
| July 08, 2026 | 3.503B |
| July 07, 2026 | 3.487B |
| July 06, 2026 | 3.412B |
| July 02, 2026 | 3.412B |
| July 01, 2026 | 3.412B |
| June 30, 2026 | 3.412B |
| June 29, 2026 | 3.404B |
| June 26, 2026 | 3.459B |
| June 25, 2026 | 3.459B |
| June 24, 2026 | 3.459B |
| June 23, 2026 | 3.459B |
| June 22, 2026 | 3.459B |
| June 18, 2026 | 3.459B |
| June 17, 2026 | 3.459B |
| June 16, 2026 | 3.459B |
| June 15, 2026 | 3.459B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sartorius AG | 15.64B |
| SCHOTT Pharma AG & Co. KGaA | 2.607B |
| Agilent Technologies, Inc. | 45.23B |
| Bio-Rad Laboratories, Inc. | 10.19B |
| Bruker Corp. | 10.32B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -357.13M |
| Revenue (Quarterly) | 744.91M |
| Total Expenses (Quarterly) | 1.102B |
| EPS Diluted (Quarterly) | -10.34 |
| Gross Profit Margin (Quarterly) | 0.28% |
| Profit Margin (Quarterly) | -47.94% |
| Earnings Yield | -33.43% |
| Normalized Earnings Yield | -15.29 |